Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted delivery to the nucleus.

Colin W Pouton1, Kylie M Wagstaff, Daniela M Roth

  • 1Department of Pharmaceutical Biology, Victorian College of Pharmacy, Monash University, Parkville, Victoria 3052, Australia. Colin.Pouton@vcp.monash.edu.au

Advanced Drug Delivery Reviews
|August 8, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting Synaptic Vesicle Endocytosis in Nociceptors Provides Sustained Pain Relief.

bioRxiv : the preprint server for biology·2026
Same author

The Nuclear Transporter Transportin-3 Functions Under Oxidative Stress.

Cells·2026
Same author

Hendra virus genotypes 1 and 2 differ in V protein-mediated immune evasion.

The Journal of general virology·2026
Same author

Age-related differences in mRNA vaccine immunogenicity and adjuvancy.

Immunology and cell biology·2026
Same author

Engineering bioinspired, high-density collagen microgels with tunable intrafibrillar mineralization for accelerated osteogenesis in vitro and bone regeneration in vivo.

Acta biomaterialia·2026
Same author

Morphological changes induced by buffer exchange during preparation of mRNA-lipid nanoparticles occur in a stepwise manner as pH is elevated.

Molecular therapy. Methods & clinical development·2026
Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026
Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026
Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026
Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026
See all related articles

Viruses exploit nuclear import mechanisms for their life cycle. Understanding these pathways can improve non-viral gene therapy delivery systems for enhanced therapeutic efficacy.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Virology

Background:

  • Nuclear transport of macromolecules is essential for cell function but tightly regulated.
  • Viruses utilize cellular nuclear import pathways for their replication and propagation.

Purpose of the Study:

  • To review mechanisms of nuclear import for endogenous molecules and viral genomes.
  • To identify opportunities and challenges in developing non-viral nuclear delivery systems for gene therapy.

Main Methods:

  • Review of published literature on nuclear transport and viral entry mechanisms.
  • Analysis of viral strategies for nuclear genome delivery.
  • Evaluation of requirements for effective non-viral delivery systems.

Main Results:

Related Experiment Videos

  • Endogenous molecules and viruses use specific pathways to enter the nucleus.
  • Past non-viral gene therapy delivery systems have had limited success.
  • Viruses offer models for designing effective nuclear delivery systems.

Conclusions:

  • Appreciating viral nuclear delivery mechanisms is crucial for advancing non-viral gene therapy.
  • Future delivery systems need to incorporate features for endosomal escape, microtubular transport, and nuclear pore complex uptake.
  • The goal is to create systems as effective as viral vectors but with reduced immunogenicity.